Moderna (MRNA) nnounced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted a positive opinion recommending marketing authorization for an updated ...

Moderna, Inc. today reported financial results and provided business updates for the third quarter of 2024.. COVID- 19: The Company reported $1.8 billion in Spikevax ® sales in the third quarter ...

2026 and 2027 Financial Updates. Moderna is expanding its cost efficiency and prioritization programs and expects estimated GAAP operating costs of $5.4 to $5.7 billion in 2026, ...

CAMBRIDGE, MA / ACCESS Newswire / April 10, 2025 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, May 1, 2025 to ...

Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, August 1, 2024 to report its second quarter 2024 financial results ...

Moderna Reports Third Quarter 2024 Financial Results and Provides Business Updates Nov. 07, 2024 6:30 AM ET Moderna, Inc. (MRNA) Q3: 2024-11-07 Earnings Summary ...